Skip to main content
Advertising

Originally published Friday, July 6, 2012 at 1:55 PM

  • Share:
           
  • Comments (0)
  • Print

Summary Box: Retailers: Pfizer delayed generics

LIPITOR LAWSUIT: Five big retail chains sued Pfizer Inc. and generic drugmaker Ranbaxy Laboratories of India in federal court, claiming they schemed to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

The Associated Press

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

LIPITOR LAWSUIT: Five big retail chains sued Pfizer Inc. and generic drugmaker Ranbaxy Laboratories of India in federal court, claiming they schemed to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

THE CLAIMS: Walgreen Co., Kroger Co, Safeway Inc., Supervalu Inc. and HEB Grocery Co. LP accuse Pfizer of fraudulently getting the patent extended for Lipitor, the world's top-selling drug ever, and then making deals to limit how much generic Lipitor pharmacies could sell. Drug stores make bigger profits on generics than brand-name drugs.

THE RESPONSE: Pfizer denies the claims and says it will defend itself vigorously. Ranbaxy had no comment.

News where, when and how you want it

Email Icon

Hurry! Last two weeks to save 15%.

Hurry! Last two weeks to save 15%.

Reserve your copy of "The Seattle Sketcher," the long-awaited book by staff artist Gabriel Campanario, for the special price of just $29.95.

Advertising

Advertising


Advertising